Sarepta Therapeutics, Inc. (SRPT)
NASDAQ: SRPT · Real-Time Price · USD
123.29
-2.71 (-2.15%)
At close: Nov 1, 2024, 4:00 PM
123.40
+0.11 (0.09%)
After-hours: Nov 1, 2024, 5:41 PM EDT
Sarepta Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Nov '24 Nov 1, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Market Capitalization | 11,758 | 9,021 | 11,375 | 7,841 | 13,454 | 9,619 | |
Market Cap Growth | 40.00% | -20.70% | 45.06% | -41.72% | 39.87% | 25.01% | |
Enterprise Value | 11,684 | 8,677 | 10,907 | 7,420 | 12,422 | 9,064 | |
Last Close Price | 123.29 | 96.43 | 129.58 | 90.05 | 170.49 | 129.04 | |
PE Ratio | 251.20 | -16.62 | -16.13 | -17.47 | -23.98 | -13.28 | |
PS Ratio | 7.81 | 7.26 | 12.19 | 11.17 | 24.91 | 25.26 | |
PB Ratio | 10.91 | 10.50 | 29.55 | 8.45 | 17.66 | 11.76 | |
P/FCF Ratio | -29.47 | -15.63 | -31.94 | -16.28 | 532.53 | -18.64 | |
P/OCF Ratio | -37.67 | -18.01 | -34.96 | -17.69 | 125.19 | -21.07 | |
EV/Sales Ratio | 7.76 | 6.98 | 11.69 | 10.57 | 23.00 | 23.80 | |
EV/EBITDA Ratio | 150.28 | -38.83 | -22.06 | -18.29 | -23.11 | -18.20 | |
EV/EBIT Ratio | 307.59 | -32.40 | -20.34 | -16.73 | -22.02 | -17.36 | |
EV/FCF Ratio | -29.48 | -15.03 | -30.62 | -15.40 | 491.69 | -17.56 | |
Debt / Equity Ratio | 1.29 | 1.63 | 4.20 | 1.23 | 1.41 | 0.89 | |
Debt / FCF Ratio | -2.74 | -2.42 | -4.54 | -2.36 | 42.47 | -1.41 | |
Asset Turnover | 0.46 | 0.39 | 0.30 | 0.23 | 0.22 | 0.22 | |
Inventory Turnover | 2.66 | 3.90 | 5.21 | 4.12 | 3.90 | 4.16 | |
Quick Ratio | 2.69 | 3.24 | 3.63 | 5.05 | 4.99 | 4.60 | |
Current Ratio | 3.90 | 3.95 | 4.13 | 5.75 | 5.97 | 5.55 | |
Return on Equity (ROE) | 5.20% | -86.15% | -107.16% | -49.57% | -70.15% | -77.29% | |
Return on Assets (ROA) | 0.72% | -5.24% | -10.68% | -9.04% | -14.67% | -18.84% | |
Return on Capital (ROIC) | 1.04% | -7.86% | -16.47% | -14.21% | -20.85% | -21.75% | |
Earnings Yield | 0.40% | -5.94% | -6.18% | -5.34% | -4.12% | -7.43% | |
FCF Yield | -4.31% | -6.40% | -3.13% | -6.14% | 0.19% | -5.37% | |
Buyback Yield / Dilution | -10.93% | -5.53% | -7.75% | -4.24% | -5.90% | -11.12% | |
Total Shareholder Return | -10.93% | -5.53% | -7.75% | -4.24% | -5.90% | -11.12% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.